Exosens raises 2026 guidance to €558 million-€570 million revenue
AI Summary- Exosens raised its full-year 2026 revenue and adjusted EBITDA guidance.
- €558 million-€570 million is the new revenue range, up from €520 million-€540 million.
- Exosens will provide 2027 guidance with full-year 2026 results on 22 February 2027.